The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases

Receptor activator of NF-kB (RANK) pathway regulates bone remodeling and is involved in breast cancer (BC) progression. Genetic polymorphisms affecting RANK-ligand (RANKL) and osteoprotegerin (OPG) have been previously associated with BC risk and bone metastasis (BM)-free survival, respectively. In...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Ferreira, Arlindo, Alho, Irina, Vendrell, Inês, Melo, Marta, Brás, Raquel, Costa, Ana Lúcia, Sousa, Ana Rita, Mansinho, André, Abreu, Catarina, Pulido, Catarina, Macedo, Daniela, Pacheco, Teresa, Correia, Lurdes, Costa, Luis, Casimiro, Sandra
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173066/
https://ncbi.nlm.nih.gov/pubmed/27191503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9356
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi